- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05303012
Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic (COBESITY-Study)
International, Prospective Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic on Two Obese Patient Cohorts Pre- and Post-bariatric Surgery (COBESITY-Study)
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
The COVID-19 pandemic, first reported in November 2019, has led to a global health systems emergency. The number of confirmed COVID-19-associated deaths, according to WHO, is higher in countries with high obesity prevalence. However, whether obesity is an independent risk factor of the severity of COVID-19 remains unclear.
Obesity represents one of the major health problems worldwide and the COVID-19 pandemic is expected to further increase obesity prevalence rates. Initial research indicates that the pandemic has also led to an increased incidence and/or worsening of depression and eating disorders. Additional weight gain due to the COVID-19 pandemic may be suspected to increase the prevalence of psychological comorbidities in patients before weight-reducing surgery compared to patients who have already undergone weight-reducing surgery.
Therefore, the main aim of this international study is to gain a better understanding of the mental and physical effects of the coronavirus pandemic on obese patients before and after a weight-reducing surgery and use this to develop approaches for solutions. This study also aims to investigate the country-specific differences (Germany vs England) as well as the differences in the mental effects experienced by overweight patients who have or have not been infected with COVID-19.
To achieve these aims, obese patients aged 18 years and older, before and after weight-reducing surgery, will be recruited from the bariatric surgery clinic at King's College Hospital, NHS Trust Foundation as well as from the Medical University Hospital Hamburg-Eppendorf, Germany. Participants will be asked to complete a questionnaire about their health, socio-economic status, and the effects of the COVID-19 pandemic on their physical and mental health. The questionnaire will take 15 minutes to complete and can be done at home or during the patient's appointment at the bariatric surgery clinic to minimise unnecessary travel.
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studiecontact
- Naam: Pia Roser, MD
- Telefoonnummer: +494074100
- E-mail: p.roser@uke.de
Studie Locaties
-
-
-
Hamburg, Duitsland
- Werving
- Universitatsklinikum Hamburg-Eppendorf
-
Contact:
- Pia Roser, MD
- Telefoonnummer: 00494074100
- E-mail: p.roser@uke.de
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
Overweight and obese patient cohort
- Age: 18 years and older
- BMI ≥ 25kg/m²
Overweight and obese patient cohort with bariatric surgery
- Age: 18 years and older
- BMI ≥ 25kg/m²
- Status post sleeve or gastric bypass surgery
Exclusion Criteria:
- Age under 18 years
- Cognitive, mental and/or linguistic limitations to complete the questionnaire independently
- Severe somatic illnesses, such as tumour diseases
- Pregnancy or breastfeeding
- Acute need for treatment due to comorbid mental disorders
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
---|
Overweight and obese patient cohort
|
Overweight and obese patient cohort with bariatric surgery
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
PHQ-4
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
PSS-10
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
EDEQ-score
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
BMI
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Impact of the COVID-19 pandemic on mental health (measured by PHQ-4, PSS-10, and EDEQ scores) as well as on physical health (measured by Δ BMI (kg/m^2) before and after the onset of the pandemic) in two obese patient cohorts pre- and post- bariatric surgery.
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Country-specific differences of the physical and psychological impact of the COVID-19 pandemic
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Differences in psychological impact in obese patients pre- and post-bariatric surgery
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Differences in psychological impact between obese patients with and without COVID-19 infection
Tijdsspanne: Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Before the COVID-19 pandemic vs. since the COVID-19 pandemic
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Pia Roser, MD, Medical University Hospital Hamburg-Eppendorf
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2021-100673
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Overgewicht en obesitas
-
Swansea UniversityVoltooidA Bite of ACT' (BOA) Acceptance and Commitment Therapy Online cursus psycho-educatie | Een wachtlijstcontroleVerenigd Koninkrijk
-
University of SheffieldMid Yorkshire Hospitals NHS TrustIngetrokkenObesitas, Acceptance and Commitment Therapy, Weight Management ServiceVerenigd Koninkrijk
-
Bambino Gesù Hospital and Research InstituteVoltooidErnstige pediatrische obesitas (BMI > 97° pc -Volgens Centers for Disease Control and Prevention BMI Charts-) | Veranderde leverfunctietesten | Glykemische intolerantieItalië
-
Alexandria UniversityVoltooidAcceptance and Commitment Therapy, geestelijke gezondheid, cognitieve stoornissen, colorectale kankerEgypte